UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel

PloS one, 2013-11, Vol.8 (11), p.e80478-e80478

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018)

BMC cancer, 2020-08, Vol.20 (1), p.822-10, Article 822

2020

Link zum Volltext

Verfügbarkeit prüfen

Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma

PloS one, 2015-09, Vol.10 (9), p.e0139264-e0139264

2015

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome

PloS one, 2010-12, Vol.5 (12), p.e14229-e14229

2010

Link zum Volltext

Verfügbarkeit prüfen

Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity

Journal of cellular biochemistry, 2013-05, Vol.114 (5), p.1135-1144

2013

Link zum Volltext

Verfügbarkeit prüfen

Demographic Analysis of Cancer Research Priorities and Treatment Correlations

Current oncology (Toronto), 2024-03, Vol.31 (4), p.1839-1864

2024

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?

Endocrine-related cancer, 2006-03, Vol.13 (1), p.3-6

2006

Link zum Volltext

Verfügbarkeit prüfen

Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer

Clinical cancer research, 2006-09, Vol.12 (17), p.5158-5164

2006

Link zum Volltext

Verfügbarkeit prüfen

Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?

Expert review of anticancer therapy, 2013-04, Vol.13 (4), p.407-420

2013

Link zum Volltext

Verfügbarkeit prüfen

HER2 signaling and resistance to the anti-EGFR monoclonal antibody cetuximab: a further step toward personalized medicine for patients with colorectal cancer

Cancer discovery, 2011-11, Vol.1 (6), p.472-474

2011

Link zum Volltext

Verfügbarkeit prüfen

ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.1682-1689

2016

Link zum Volltext

Verfügbarkeit prüfen

EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study

Lung cancer (Amsterdam, Netherlands), 2017-11, Vol.113, p.37-44

2017

Link zum Volltext

Verfügbarkeit prüfen

EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey

Journal of thoracic oncology, 2015-03, Vol.10 (3), p.438-445

2015

Link zum Volltext

Verfügbarkeit prüfen

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma

Oncotarget, 2016-10, Vol.7 (41), p.66595-66605

2016

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of circulating tumor cells’ reduction in patients with extensive small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2014-08, Vol.85 (2), p.314-319

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factor for non-small cell lung cancer with bone metastases at the time of diagnosis

Lung cancer (Amsterdam, Netherlands), 2012-11, Vol.78 (2), p.168-168

2012

Link zum Volltext

Verfügbarkeit prüfen

Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells

Oncotarget, 2017-06, Vol.8 (26), p.42926-42938

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2016-09, Vol.99, p.31-37

2016

Link zum Volltext

Verfügbarkeit prüfen

The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies

Cancer biology & therapy, 2013-12, Vol.14 (12), p.1143-1146

2013

Link zum Volltext

Verfügbarkeit prüfen

Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity

Journal of translational medicine, 2016-02, Vol.14 (61), p.61-61, Article 61

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Science & Technology
(32)
Life Sciences & Biomedicine
(29)
Oncology
(29)
Female
(28)
Aged
(18)
Middle Aged
(18)
Lung Neoplasms - Genetics
(12)
Mutation
(12)
Lung Neoplasms - Pathology
(10)
Receptor, Epidermal Growth Factor - Genetics
(10)
Tumors
(10)
Adult
(9)
Respiratory System
(9)
Cancer
(8)
Prognosis
(8)
Adenocarcinoma - Genetics
(7)
Antineoplastic Agents - Therapeutic Use
(7)
Carcinoma, Non-Small-Cell Lung - Genetics
(7)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer

Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018)

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer

Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma

Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome

Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity

Demographic Analysis of Cancer Research Priorities and Treatment Correlations

Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?

Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer

Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?

HER2 signaling and resistance to the anti-EGFR monoclonal antibody cetuximab: a further step toward personalized medicine for patients with colorectal cancer

ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study

EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial

EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma

Prognostic value of circulating tumor cells’ reduction in patients with extensive small-cell lung cancer

Prognostic factor for non-small cell lung cancer with bone metastases at the time of diagnosis

Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer

The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies

Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity

Survival After Surgical Treatment of Lung Cancer Arising in the Population Exposed to Illegal Dumping of Toxic Waste in the Land of Fires ('Terra dei Fuochi') of Southern Italy

Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study

Aktive Filter

Suchergebnisse filtern